#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antithrombin III deficiency Allogenic stem cell transplantation Erdheim-Chester disease Neuroendocrine carcinoma of the skin Renal disorder Trigeminal neuralgia Polyneuropathy Amyotrophic lateral sclerosis Nasopharyngeal cancer Warm autoimmune haemolytic anaemia Selective polysaccharide antibody deficiency Pyruvate dehydrogenase complex deficiency Nephrotic syndrome Anal fistula Mitochondrial DNA depletion More trials…

    Learn about Rare Diseases

    Alport’s syndrome – Trials in Disease Turner’s syndrome Haemolytic uraemic syndrome – Life with Disease Shprintzen-Goldberg syndrome – Life with Disease Factor IX deficiency Nephroblastoma Hereditary angioedema – Trials in Disease Hereditary optic atrophy – Treatment Rett syndrome – Life with Disease Medulloblastoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo1A Adrc Ag-946 Phosphate GUAIACOL Ads-011 Darbepoetin Alfa Difelikefalin Vorinostat Lenacapavir Sodium Iomeprol Pyruvic Acid Betula Pendula Pollen Extract Indacaterol Acetate 534 CHLORMADINONE ACETATE Radotinib Dihydrochloride Baricitinib Catequentinib Dihydrochloride TRIACYLGLYCEROL LIPASE Testosterone More therapies…

    Learn about Your Condition

    Porphyria non-acute Meniscus operation Coeliac disease Erythema multiforme Femoral neck fracture Endometrial adenocarcinoma Fontan procedure Nephropathy Prolymphocytic leukaemia Lower limb fracture Traumatic pain Gastric cancer stage IV Laryngeal cancer stage II Oesophageal adenocarcinoma Macular degeneration More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glycogen storage disease type II

  • A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

    Recruiting

    2 1
    Belgium Denmark France Germany Italy The Netherlands +1

  • Study on the Safety and Effects of SPK-3006 for Adults with Late-Onset Pompe Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Vanglusagene Ensiparvovec
    Germany

  • Study on Reducing Treatment Frequency of Alglucosidase Alfa for Elderly Patients with Late-Onset Pompe Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Alglucosidase Alfa
    • Avalglucosidase Alfa
    • Cipaglucosidase Alfa
    The Netherlands

  • Study on the Safety and Effects of Cipaglucosidase Alfa and Miglustat for Children with Infantile-onset Pompe Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Cipaglucosidase Alfa
    • Miglustat
    Denmark France Germany Italy The Netherlands

  • Study on the Effects of Avalglucosidase Alfa Enzyme Replacement Therapy in Patients with Pompe Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Avalglucosidase Alfa
    Denmark

  • Study on Gene Therapy with AAV9.LAMP2B for Male Patients with Danon Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 9 Vector Containing The Human Lamp2 Isoform B Transgene
    • Eculizumab
    • Sirolimus
    Germany Italy
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!